|
Cerebrovascular Disease
Citations 121-130 of 236 total displayed.
|
Past content
(since Feb 1998):
|
- Clinical Reviews
Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease
- Huyen Tran; Sonia S. Anand
JAMA 2004; 292: 1867-1874.
[Abstract]
[Full text]
[PDF]
- Editorials
Treatment of Acute Stroke: Still Struggling
- Louis R. Caplan
JAMA 2004; 292: 1883-1885.
[Extract]
[Full text]
[PDF]
- Editorials
Stroke Prevention: Optimizing the Response to a Common Threat
- James F. Toole; David C. Sane; Kerstin Bettermann
JAMA 2004; 292: 1885-1887.
[Extract]
[Full text]
[PDF]
- JAMA Patient Page
Hemorrhagic Stroke
- Sharon Parmet; Tiffany J. Glass; Richard M. Glass
JAMA 2004; 292: 1916.
[Extract]
[Full text]
[PDF]
- Letters
Antiphospholipid Antibodies and Risk for Recurrent Vascular Events
- Denis Wahl; Véronique Regnault; Philippe de Moerloose; Thomas Lecompte
JAMA 2004; 291: 2701-b-2702-b.
[Extract]
[Full text]
[PDF]
- Letters
Antiphospholipid Antibodies and Risk for Recurrent Vascular Events
- Guillermo Ruiz-Irastorza; Munther A. Khamashta; Graham R. V. Hughes
JAMA 2004; 291: 2701-a.
[Extract]
[Full text]
[PDF]
- Letters
Antiphospholipid Antibodies and Risk for Recurrent Vascular Events
- Antonio R. Cabral
JAMA 2004; 291: 2701.
[Extract]
[Full text]
[PDF]
- Letters
Antiphospholipid Antibodies and Risk for Recurrent Vascular Events—Reply
- Steven R. Levine; Robin L. Brey; Barbara C. Tilley; Douglas A. Triplett; J. L. P. Thompson; Ralph L. Sacco; J. P. Mohr; for the APASS Investigators
JAMA 2004; 291: 2702-2703.
[Extract]
[Full text]
[PDF]
- Letters
Vitamin Supplementation and Risk of Stroke—Reply
- J. David Spence; James F. Toole; Lloyd E. Chambless; Chin-Hua Wang; Meir Stampfer; L. Creed Pettigrew; Virginia J. Howard; Elizabeth G. Sides
JAMA 2004; 291: 2191-b-2192-b.
[Extract]
[Full text]
[PDF]
- Letters
Vitamin Supplementation and Risk of Stroke
- David S. Wald
JAMA 2004; 291: 2191-a.
[Extract]
[Full text]
[PDF]
|
|
